简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Paratek Pharmaceuticals Analyst Ratings

2023-08-07 18:56

What is the target price for Paratek Pharmaceuticals (PRTK)?The latest price target for Paratek Pharmaceuticals (NASDAQ: PRTK) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $2.15 expecting PRTK to fall to within 12 months (a possible -3.15% downside). 5 analyst firms have reported ratings in the last year.What is the most recent analyst rating for Paratek Pharmaceuticals (PRTK)?The latest analyst rating for Paratek Pharmaceuticals (NASDAQ: PRTK) was provided by HC Wainwright & Co., and Paratek Pharmaceuticals reiterated their neutral rating.When is the next analyst rating going to be posted or

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。